We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > breast cancers

News List

Pfizer’s biosimilar to Roche’s Herceptin receives approval from FDA pharmaceutical-technology
March 14, 2019
Pfizer has secured approval from the US Food and Drug Administration (FDA) for its drug Trazimera (trastuzumab-qyyp), a biosimilar medicine to Roche’s Herceptin (trastuzumab).
Daiichi Sankyo Initiates Pivotal Phase 3 Trial of [Fam-] DS-8201 americanpharmaceuticalreview
January 15, 2019
Daiichi Sankyo announced that the first patient has been dosed in DESTINY-Breast04, a global pivotal phase 3 study evaluating the safety and efficacy of [fam-] trastuzumab deruxtecan (DS-8201)....
Combined Digital Screening Best for Detecting Breast Cancers drugs
August 07, 2018
The combination of digital mammography (DM) and digital breast tomosynthesis (DBT) detects 90 percent more breast cancers than digital mammography alone, according to a study published in the August issue of Radiology.
MRI succeed in detecting breast cancers after pregnancy europeanpharmaceuticalreview
September 18, 2017
MRI examination has shown effective in detecting pregnancy-associated breast cancer.
FDA accepts BLA for Mylan and Biocon's proposed biosimilar trastuzumab cphi-online
January 13, 2017
If approved, MYL-1401O has potential to be the first biosimilar trastuzumab in the US.